- This event has passed.
BIA: Pathway of Innovation from Research to Patients
The fifth joint UK BioIndustry Association (BIA) and Medicines and Healthcare Products Regulatory Agency (MHRA) conference – Pathway of Innovation from Research to Patients takes place on Thursday 11 June in central London and we invite you to reserve your place today.
This one-day leading regulatory conference provides the opportunity to showcase the collaborative approach between stakeholders to support innovation and to facilitate clinical development and timely access to new treatments and vaccines.
The conference will be the ideal place to hear the very latest thinking from senior experts and leading speakers from the MHRA and the National Institute for Biological Standards and Control (NIBSC), the life science industry, the Wellcome Trust, the Jenner Institute and patient organisations.
Speakers include:
- Professor Mary Collins, Head of Advanced Therapies Unit, NIBSC
- Emily Crossley, Duchenne Children’s Trust
- Lesley Green, Vice Chair, Committee for Orphan Medicinal Products (COMP), European Medicines Agency, and Patient Advocate for EURORDIS
- Professor Adrian Hill, Director, Jenner Institute, University of Oxford
- Dr Janine Jolly, Head of Patient, Public and Stakeholder Engagement, Medicines and Healthcare Products Regulatory Agency
- Dr Siu Ping Lam, Director, Licensing Division, MHRA
- Dr Tom Lillie, Oncology International Therapeutic Head, Amgen
- Dr Martin O’Kane, Manager, Clinical Trials Unit, MHRA
- Kathy Oliver, International Brain Tumour Alliance
- Dr Mark Page, Principal Scientist, NIBSC
- Professor Sir Michael Rawlins, Chairman, Medicines and Healthcare Products Regulatory Agency
- Dr Lincoln Tsang, Partner, Arnold & Porter and Member, BIA Regulatory Affairs Advisory Committee
- Professor Mike Turner, Head of Infection and Immunobiology, Wellcome Trust
Full programme details can be found here
Contact Tess for your 10% non member discount code